Tyra Biosciences Ownership 2024 | Who Owns Tyra Biosciences Now?
Institutional Ownership
24.35%
Insider Ownership
4.67%
Retail Ownership
70.99%
Institutional Holders
37.00
Tyra Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 19.94% | 2.20% | 10,416,609 | - | - | 166,561,578 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 12.35% | 5.43% | 6,448,359 | - | - | 103,109,260 | Jun 30, 2024 |
| BVF INC/IL | 8.92% | 2.09% | 4,661,194 | - | - | 74,532,492 | Jun 30, 2024 |
| CANAAN PARTNERS XI LLC | 8.44% | 85.38% | 4,409,991 | - | - | 70,515,756 | Jun 30, 2024 |
| NEXTECH INVEST LTD. | 7.77% | 10.91% | 4,055,861 | - | - | 64,853,217 | Jun 30, 2024 |
| FMR LLC | 6.41% | 0.00% | 3,346,663 | -630,545 | -15.85% | 53,513,146 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 3.81% | 3.31% | 1,989,103 | - | - | 31,805,757 | Jun 30, 2024 |
| BLACKROCK INC. | 2.72% | 0.00% | 1,418,855 | 374,630 | 35.88% | 22,687,491 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.37% | 0.00% | 1,238,501 | 338,701 | 37.64% | 19,803,631 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.93% | 0.38% | 1,007,367 | 338,208 | 50.54% | 16,107,798 | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 1.80% | 3.36% | 939,298 | - | - | 15,019,375 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.59% | 0.62% | 832,220 | - | - | 13,307,198 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 1.47% | 0.24% | 768,638 | - | - | 12,290,522 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 1.15% | 2.60% | 600,294 | 64,553 | 12.05% | 9,598,701 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 1.09% | 0.70% | 566,715 | 51,525 | 10.00% | 9,061,773 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.00% | 0.00% | 522,674 | 105,866 | 25.40% | 8,359,039 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.71% | 0.25% | 373,000 | 373,000 | 100.00% | 5,964,270 | Jun 30, 2024 |
| STATE STREET CORP | 0.71% | 0.00% | 368,484 | 76,250 | 26.09% | 5,892,059,000 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.70% | 0.00% | 364,751 | -15,846 | -4.16% | 5,832,368 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 0.51% | 2.52% | 264,660 | 264,660 | 100.00% | 4,231,913 | Jun 30, 2024 |
Tyra Biosciences's largest institutional shareholder is RA CAPITAL MANAGEMENT, L.P., holding 19.94% of the company's total share outstanding, currently valued at $166.56M. The top 10 institutional shareholders own together 74.66% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CANAAN PARTNERS XI LLC | 8.44% | 85.38% | 4,409,991 | - | - | 70,515,756 | Jun 30, 2024 |
| NEXTECH INVEST LTD. | 7.77% | 10.91% | 4,055,861 | - | - | 64,853,217 | Jun 30, 2024 |
| BOXER CAPITAL, LLC | 12.35% | 5.43% | 6,448,359 | - | - | 103,109,260 | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 1.80% | 3.36% | 939,298 | - | - | 15,019,375 | Jun 30, 2024 |
| TCG CROSSOVER MANAGEMENT, LLC | 3.81% | 3.31% | 1,989,103 | - | - | 31,805,757 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 1.15% | 2.60% | 600,294 | 64,553 | 12.05% | 9,598,701 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 0.51% | 2.52% | 264,660 | 264,660 | 100.00% | 4,231,913 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 19.94% | 2.20% | 10,416,609 | - | - | 166,561,578 | Jun 30, 2024 |
| BVF INC/IL | 8.92% | 2.09% | 4,661,194 | - | - | 74,532,492 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 1.09% | 0.70% | 566,715 | 51,525 | 10.00% | 9,061,773 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 1.59% | 0.62% | 832,220 | - | - | 13,307,198 | Jun 30, 2024 |
| AUOUR INVESTMENTS LLC | 0.16% | 0.51% | 85,020 | - | - | 1,359,470 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.93% | 0.38% | 1,007,367 | 338,208 | 50.54% | 16,107,798 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.71% | 0.25% | 373,000 | 373,000 | 100.00% | 5,964,270 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 1.47% | 0.24% | 768,638 | - | - | 12,290,522 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.03% | 0.09% | 16,078 | 16,078 | 100.00% | 257,087 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.08% | 0.07% | 42,223 | 42,223 | 100.00% | 675,146 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.01% | 0.04% | 4,560 | 4,560 | 100.00% | 72,914 | Jun 30, 2024 |
| PARKWOOD LLC | 0.03% | 0.03% | 14,056 | 14,056 | 100.00% | 225,000 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.03% | 0.02% | 15,306 | 3,132 | 25.73% | 244,743 | Jun 30, 2024 |
The largest Tyra Biosciences shareholder by % of total assets is CANAAN PARTNERS XI LLC. The company owns 4.41M shares of Tyra Biosciences (TYRA), representing 85.38% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BLACKROCK INC. | 2.72% | 0.00% | 1,418,855 | 374,630 | 35.88% | 22,687,491 | Jun 30, 2024 |
| AVIDITY PARTNERS MANAGEMENT LP | 0.71% | 0.25% | 373,000 | 373,000 | 100.00% | 5,964,270 | Jun 30, 2024 |
| VANGUARD GROUP INC | 2.37% | 0.00% | 1,238,501 | 338,701 | 37.64% | 19,803,631 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 1.93% | 0.38% | 1,007,367 | 338,208 | 50.54% | 16,107,798 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 0.51% | 2.52% | 264,660 | 264,660 | 100.00% | 4,231,913 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.36% | 0.01% | 190,557 | 190,557 | 100.00% | 3,047,006 | Jun 30, 2024 |
| JENNISON ASSOCIATES LLC | 0.29% | 0.00% | 149,350 | 149,350 | 100.00% | 2,388,107 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.33% | 0.00% | 170,283 | 145,346 | 582.85% | 2,722,825 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.00% | 0.00% | 522,674 | 105,866 | 25.40% | 8,359,039 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.22% | 0.00% | 114,874 | 100,797 | 716.04% | 1,836,836 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.17% | 0.01% | 88,656 | 88,656 | 100.00% | 1,417,609 | Jun 30, 2024 |
| STATE STREET CORP | 0.71% | 0.00% | 368,484 | 76,250 | 26.09% | 5,892,059,000 | Jun 30, 2024 |
| NUVEEN ASSET MANAGEMENT, LLC | 0.18% | 0.00% | 92,658 | 66,945 | 260.35% | 1,481,602 | Jun 30, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 1.15% | 2.60% | 600,294 | 64,553 | 12.05% | 9,598,701 | Jun 30, 2024 |
| KYNAM CAPITAL MANAGEMENT, LP | 1.09% | 0.70% | 566,715 | 51,525 | 10.00% | 9,061,773 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.08% | 0.07% | 42,223 | 42,223 | 100.00% | 675,146 | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | 0.07% | 0.00% | 38,065 | 38,065 | 100.00% | 608,659 | Jun 30, 2024 |
| MORGAN STANLEY | 0.12% | 0.00% | 64,531 | 29,294 | 83.13% | 1,031,851 | Jun 30, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.33% | 0.00% | 169,945 | 17,733 | 11.65% | 2,717,421 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.03% | 0.00% | 17,570 | 17,570 | 100.00% | 280,944 | Jun 30, 2024 |
As of Jun 30 2024, Tyra Biosciences's largest institutional buyer is BLACKROCK INC.. The company purchased 374.63K stocks of TYRA, valued at $22.69M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FAIRMOUNT FUNDS MANAGEMENT LLC | - | - | - | -1,393,329 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | 6.41% | 0.00% | 3,346,663 | -630,545 | -15.85% | 53,513,146 | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | - | - | - | -381,210 | -100.00% | - | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | - | - | - | -203,709 | -100.00% | - | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -152,968 | -100.00% | - | Jun 30, 2024 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.33% | 0.02% | 170,717 | -101,433 | -37.27% | 2,730,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -54,400 | -100.00% | - | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.00% | 0.00% | 300 | -28,000 | -98.94% | 4,797 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.01% | 0.00% | 7,423 | -24,726 | -76.91% | 119,000 | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | - | - | - | -20,259 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -19,643 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 0.70% | 0.00% | 364,751 | -15,846 | -4.16% | 5,832,368 | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -13,317 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -10,750 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -7,032 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -6,892 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.01% | - | 7,575 | -6,597 | -46.55% | 121,124 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.07% | 0.00% | 35,272 | -6,470 | -15.50% | 563,999 | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.02% | 0.00% | 12,245 | -3,808 | -23.72% | 195,798 | Jun 30, 2024 |
| FISHMAN JAY A LTD/MI | 0.02% | 0.02% | 12,500 | -2,500 | -16.67% | 199,875 | Jun 30, 2024 |
As of Jun 30 2024, Tyra Biosciences's biggest institutional seller is FAIRMOUNT FUNDS MANAGEMENT LLC. The company sold -1.39M shares of TYRA, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AVIDITY PARTNERS MANAGEMENT LP | 0.71% | 0.25% | 373,000 | 373,000 | 100.00% | 5,964,270 | Jun 30, 2024 |
| ALLY BRIDGE GROUP (NY) LLC | 0.51% | 2.52% | 264,660 | 264,660 | 100.00% | 4,231,913 | Jun 30, 2024 |
| ENSIGN PEAK ADVISORS, INC | 0.36% | 0.01% | 190,557 | 190,557 | 100.00% | 3,047,006 | Jun 30, 2024 |
| JENNISON ASSOCIATES LLC | 0.29% | 0.00% | 149,350 | 149,350 | 100.00% | 2,388,107 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.17% | 0.01% | 88,656 | 88,656 | 100.00% | 1,417,609 | Jun 30, 2024 |
| TANG CAPITAL MANAGEMENT LLC | 0.08% | 0.07% | 42,223 | 42,223 | 100.00% | 675,146 | Jun 30, 2024 |
| STATE OF WISCONSIN INVESTMENT BOARD | 0.07% | 0.00% | 38,065 | 38,065 | 100.00% | 608,659 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.03% | 0.00% | 17,570 | 17,570 | 100.00% | 280,944 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | 0.03% | 0.09% | 16,078 | 16,078 | 100.00% | 257,087 | Jun 30, 2024 |
| PARKWOOD LLC | 0.03% | 0.03% | 14,056 | 14,056 | 100.00% | 225,000 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.02% | 0.00% | 10,931 | 10,931 | 100.00% | 174,787 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.01% | 0.00% | 6,508 | 6,508 | 100.00% | 104,063 | Jun 30, 2024 |
| VIRTUS ETF ADVISERS LLC | 0.01% | 0.04% | 4,560 | 4,560 | 100.00% | 72,914 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 34 | 34 | 100.00% | 544 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | - | - | 7 | 7 | 100.00% | 112 | Jun 30, 2024 |
Tyra Biosciences's largest new institutional shareholder by number of shares is AVIDITY PARTNERS MANAGEMENT LP, purchased 373.00K shares, valued at $5.96M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FAIRMOUNT FUNDS MANAGEMENT LLC | - | - | - | -1,393,329 | -100.00% | - | Jun 30, 2024 |
| FIRST TURN MANAGEMENT, LLC | - | - | - | -381,210 | -100.00% | - | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | - | - | - | -203,709 | -100.00% | - | Jun 30, 2024 |
| NICHOLAS INVESTMENT PARTNERS, LP | - | - | - | -152,968 | -100.00% | - | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -54,400 | -100.00% | - | Jun 30, 2024 |
| LEGATO CAPITAL MANAGEMENT LLC | - | - | - | -20,259 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -19,643 | -100.00% | - | Jun 30, 2024 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -13,317 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | - | - | - | -10,750 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -7,032 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -6,892 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -1,345 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -814 | -100.00% | - | Jun 30, 2024 |
| IKARIAN CAPITAL, LLC | - | - | - | -501 | -100.00% | - | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -100 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
Tyra Biosciences's largest sold out institutional shareholder by shares sold is FAIRMOUNT FUNDS MANAGEMENT LLC, sold -1.39M shares, valued at -, as of undefined.
Tyra Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY ADVISOR SERIES VII | 0.07% | 604,900 | 308,300 | 103.94% | Jan 31, 2024 |
| FIDELITY CAPITAL TRUST | 0.04% | 419,443 | 7,600 | 1.85% | Jan 31, 2024 |
| Vericimetry Funds | 0.03% | 2,640 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 12,400 | - | - | Mar 31, 2024 |
| FIDELITY SECURITIES FUND | 0.02% | 1,839,248 | 153,901 | 9.13% | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 20,587 | 5,360 | 35.20% | Feb 29, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 24,587 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 2,162 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 798,553 | -68,431 | -7.89% | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 50,705 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 76,100 | -33,800 | -30.76% | Feb 29, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 212,000 | -186,000 | -46.73% | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 32,040 | -1,020 | -3.09% | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 39,541 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 15,907 | 7,600 | 91.49% | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 157,150 | 10,380 | 7.07% | Feb 29, 2024 |
| Voya INVESTORS TRUST | 0.00% | 33,603 | -2,490 | -6.90% | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 133,882 | -31,244 | -18.92% | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 11,212 | 1,795 | 19.06% | Feb 29, 2024 |
| SEASONS SERIES TRUST | 0.00% | 11,201 | -622 | -5.26% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 940 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 6,763 | -729 | -9.73% | Mar 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 2,142 | 1,585 | 284.56% | Feb 29, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 850 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 23,007 | -5,730 | -19.94% | Mar 28, 2024 |
| Global X Funds | 0.00% | 6,382 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 4,584 | -1,300 | -22.09% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 664 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 76,686 | 479 | 0.63% | Feb 29, 2024 |
| JPMorgan Trust I | 0.00% | 153,139 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 356 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 12,155 | 2,610 | 27.34% | Feb 29, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 7,595 | 7,595 | - | Feb 29, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 4,907 | 700 | 16.64% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 698 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 854 | 148 | 20.96% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 61,827 | 7,016 | 12.80% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 127 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 497,709 | -29,390 | -5.58% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 34,575 | -121 | -0.35% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 5,367 | -22 | -0.41% | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 44,479 | 3,831 | 9.42% | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 500 | - | - | Mar 28, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 2,120 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 63 | - | - | Dec 31, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,566 | -10 | -0.63% | Jan 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 70 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 109 | -9 | -7.63% | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 2,048 | 260 | 14.54% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 8 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 6,957 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 18,400 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 599 | - | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 4,942 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 5,489 | 1,701 | 44.90% | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 1,584 | -7 | -0.44% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 256 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 6,414 | 73 | 1.15% | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 9,291 | 174 | 1.91% | Mar 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 5,224 | -116 | -2.17% | Mar 31, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 59 | 14 | 31.11% | Jan 31, 2024 |
| Bridge Builder Trust | 0.00% | 4,419 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 979 | - | - | Dec 31, 2023 |
| FIDELITY SUMMER STREET TRUST | 0.00% | 150 | - | - | Jan 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 2,846 | - | - | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 1,546 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,771 | 23 | 1.32% | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 2,600 | - | - | Feb 29, 2024 |
Tyra Biosciences's largest mutual fund holder by % of total assets is "FIDELITY ADVISOR SERIES VII", owning 604.90K shares, compromising 0.07% of its total assets.
Tyra Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 37 | -52.56% |
| 31 Mar, 24 | 78 | 21.88% |
| 31 Dec, 23 | 64 | 8.47% |
| 30 Sep, 23 | 59 | - |
| 30 Jun, 23 | 59 | 13.46% |
| 31 Mar, 23 | 52 | 10.64% |
| 31 Dec, 22 | 47 | - |
| 30 Sep, 22 | 47 | 4.44% |
| 30 Jun, 22 | 45 | -2.17% |
| 31 Mar, 22 | 46 | 2.22% |
| 31 Dec, 21 | 45 | 73.08% |
| 30 Sep, 21 | 26 | - |
As of 30 Jun 24, 37 institutions are holding Tyra Biosciences's shares, representing a decrease of -52.56% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 12,716,585 | -72.86% |
| 31 Mar, 24 | 46,852,117 | 31.03% |
| 31 Dec, 23 | 35,756,693 | -1.94% |
| 30 Sep, 23 | 36,462,633 | 0.70% |
| 30 Jun, 23 | 36,210,809 | 1.53% |
| 31 Mar, 23 | 35,666,024 | 1.21% |
| 31 Dec, 22 | 35,239,879 | -1.27% |
| 30 Sep, 22 | 35,693,315 | -0.14% |
| 30 Jun, 22 | 35,744,418 | -1.08% |
| 31 Mar, 22 | 36,133,976 | 2.73% |
| 31 Dec, 21 | 35,174,367 | 34.87% |
| 30 Sep, 21 | 26,080,764 | - |
Tyra Biosciences (TYRA) has 12.72M shares outstanding as of 30 Jun 24, down -72.86% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 24.35% | 0.30% |
| 31 Mar, 24 | 89.71% | 1.28% |
| 31 Dec, 23 | 83.73% | 1.16% |
| 30 Sep, 23 | 85.06% | 1.18% |
| 30 Jun, 23 | 85.02% | 1.20% |
| 31 Mar, 23 | 84.13% | 1.21% |
| 31 Dec, 22 | 83.49% | 1.16% |
| 30 Sep, 22 | 84.99% | 1.16% |
| 30 Jun, 22 | 85.56% | 1.13% |
| 31 Mar, 22 | 86.96% | 1.20% |
| 31 Dec, 21 | 85.16% | 1.70% |
| 30 Sep, 21 | 70.84% | - |
As of 30 Jun 24, Tyra Biosciences is held by 24.35% institutional shareholders, representing a 0.30% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 21 | -54.35% |
| 31 Mar, 24 | 46 | 43.75% |
| 31 Dec, 23 | 32 | 60.00% |
| 30 Sep, 23 | 20 | -28.57% |
| 30 Jun, 23 | 28 | - |
| 31 Mar, 23 | 28 | 64.71% |
| 31 Dec, 22 | 17 | -15.00% |
| 30 Sep, 22 | 20 | -4.76% |
| 30 Jun, 22 | 21 | 10.53% |
| 31 Mar, 22 | 19 | -45.71% |
| 31 Dec, 21 | 35 | 34.62% |
| 30 Sep, 21 | 26 | - |
21 institutional shareholders have increased their position in TYRA stock as of 30 Jun 24 compared to 46 in the previous quarter (a -54.35% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 11 | -31.25% |
| 31 Mar, 24 | 16 | 33.33% |
| 31 Dec, 23 | 12 | -25.00% |
| 30 Sep, 23 | 16 | 14.29% |
| 30 Jun, 23 | 14 | 55.56% |
| 31 Mar, 23 | 9 | -18.18% |
| 31 Dec, 22 | 11 | -26.67% |
| 30 Sep, 22 | 15 | -6.25% |
| 30 Jun, 22 | 16 | -15.79% |
| 31 Mar, 22 | 19 | 171.43% |
| 31 Dec, 21 | 7 | - |
| 30 Sep, 21 | - | - |
11 institutional shareholders have reduced their position in TYRA stock as of 30 Jun 24 compared to 16 in the previous quarter (a -31.25% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 37 | -52.56% | 12,716,585 | -72.86% | 24.35% | 0.30% | 21 | -54.35% | 11 | -31.25% |
| 31 Mar, 24 | 78 | 21.88% | 46,852,117 | 31.03% | 89.71% | 1.28% | 46 | 43.75% | 16 | 33.33% |
| 31 Dec, 23 | 64 | 8.47% | 35,756,693 | -1.94% | 83.73% | 1.16% | 32 | 60.00% | 12 | -25.00% |
| 30 Sep, 23 | 59 | - | 36,462,633 | 0.70% | 85.06% | 1.18% | 20 | -28.57% | 16 | 14.29% |
| 30 Jun, 23 | 59 | 13.46% | 36,210,809 | 1.53% | 85.02% | 1.20% | 28 | - | 14 | 55.56% |
| 31 Mar, 23 | 52 | 10.64% | 35,666,024 | 1.21% | 84.13% | 1.21% | 28 | 64.71% | 9 | -18.18% |
| 31 Dec, 22 | 47 | - | 35,239,879 | -1.27% | 83.49% | 1.16% | 17 | -15.00% | 11 | -26.67% |
| 30 Sep, 22 | 47 | 4.44% | 35,693,315 | -0.14% | 84.99% | 1.16% | 20 | -4.76% | 15 | -6.25% |
| 30 Jun, 22 | 45 | -2.17% | 35,744,418 | -1.08% | 85.56% | 1.13% | 21 | 10.53% | 16 | -15.79% |
| 31 Mar, 22 | 46 | 2.22% | 36,133,976 | 2.73% | 86.96% | 1.20% | 19 | -45.71% | 19 | 171.43% |
| 31 Dec, 21 | 45 | 73.08% | 35,174,367 | 34.87% | 85.16% | 1.70% | 35 | 34.62% | 7 | - |
| 30 Sep, 21 | 26 | - | 26,080,764 | - | 70.84% | - | 26 | - | - | - |
Tyra Biosciences Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Tyra Biosciences's stock was made by KAPLAN GILLA on Jun 18 2024, selling 61,392 shares at $0.61 per share (valued at $37.45K).
Tyra Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 3 | - | - |
| Q2 2024 | 10 | 5 | 200.00% |
| Q1 2024 | 8 | 18 | 44.44% |
| Q3 2023 | 15 | 17 | 88.24% |
| Q2 2023 | 20 | 37 | 54.05% |
| Q1 2023 | 20 | 30 | 66.67% |
| Q4 2022 | - | 1 | - |
| Q3 2022 | 11 | - | - |
| Q2 2022 | 12 | - | - |
| Q1 2022 | - | 3 | - |
| Q4 2021 | 15 | - | - |
| Q3 2021 | 23 | 50 | 46.00% |
3 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Tyra Biosciences's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | 2 | - |
| Q1 2024 | - | 17 | - |
| Q3 2023 | - | 9 | - |
| Q2 2023 | - | 25 | - |
| Q1 2023 | - | 12 | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 5 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Tyra Biosciences's stocks.
Tyra Biosciences Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| PMVP | PMV Pharmaceuticals, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| IKNA | Ikena Oncology, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| IPSC | Century Therapeutics, Inc. |
| ERAS | Erasca, Inc. |
| CNTB | Connect Biopharma Holdings Limited |
| CCCC | C4 Therapeutics, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| DSGN | Design Therapeutics, Inc. |
| PHVS | Pharvaris N.V. |
| HOWL | Werewolf Therapeutics, Inc. |
| XLO | Xilio Therapeutics, Inc. |
| MOLN | Molecular Partners AG |
| RAPT | RAPT Therapeutics, Inc. |
TYRA Ownership FAQ
Who Owns Tyra Biosciences?
Tyra Biosciences is owned by institutional shareholders (24.35%), insiders (4.67%), and public (70.99%). The largest institutional shareholder of Tyra Biosciences is RA CAPITAL MANAGEMENT, L.P. (19.94% of total shares) and the top mutual fund owner is FIDELITY ADVISOR SERIES VII (0.07% of total shares).
Who are the major institutional shareholders of Tyra Biosciences?
Tyra Biosciences's major institutional shareholders are RA CAPITAL MANAGEMENT, L.P., BOXER CAPITAL, LLC, BVF INC/IL, CANAAN PARTNERS XI LLC, and NEXTECH INVEST LTD.. The top five shareholders own together 57.42% of the company's share outstanding.
How many Tyra Biosciences shareholders are there?
As of Jun 2024, there are 37 institutional shareholders of Tyra Biosciences.
What percentage of Tyra Biosciences is owned by RA CAPITAL MANAGEMENT, L.P?
RA CAPITAL MANAGEMENT, L.P owns 10.42M shares of Tyra Biosciences, representing 19.94% of the company's total shares outstanding, valued at $166.56M (as of Jun 2024).
What percentage of Tyra Biosciences is owned by BOXER CAPITAL, LLC?
As of Jun 2024, BOXER CAPITAL, LLC holds 6.45M shares of Tyra Biosciences (TYRA), compromising 12.35% of the company, valued at $103.11M.
What percentage of Tyra Biosciences is owned by BVF INC/IL?
BVF INC/IL is the third largest holder of Tyra Biosciences. The company owns 4.66M of the company's shares outstanding (worth $74.53M).